Way more than an everyday interest in IP
As keepers of the world’s ‘big data’, many of the major tech companies are naturally well placed to turn to the data-hungry development of artificial intelligence, or AI. And while AI is a hot topic in almost every industry, its presence and potential application in healthcare is exploding. AI – what is it exactly? In read more…
For those readers interested in the issues surrounding competitive moves by pharmaceutical companies in the scenario where a key patent comes to an end, we report on the recent decision of the Full Federal Court in the ACCC v Pfizer matter here: ACCC v Pfizer – KWM News & Insights
15 years has passed since the Human Genome Project, involving the identification and mapping of all the genes of the human genome, was declared complete. Work on the project (which formally started in 1990 and spanned 15 years) involved international collaboration between scores of scientific researchers and funding of ~US$3 billion. As one of the read more…
With the latest Scientific American, Worldwide Scorecard ranking Australia in the top five bio-economies globally, Australia’s biotechnology and life sciences sector continues to show healthy performance for the fifth consecutive year. Despite the challenges of the global economy, there has been generally positive sentiment from an industry that is expected to continue growing, reaching close read more…
Biotechnology companies and generic pharmaceuticals are the winners and celebrities are the Biggest Losers in some intellectual property-related measures in last night’s Australian Federal Budget. Below, we set out the three key areas of interest from our first reading. Swap it! Boost for generic and biosimilar awareness campaigns The Budget will fund measures to increase the use read more…
Update: The Australian Grand Prix corporation assigned its Australian trade mark application to Formula One Licensing B.V. on 16 May 2018. You might have heard of the shadow boxing match between the Formula One’s licensing arm and The Mad Hueys – well, as of 2 May 2018, the Australian Grand Prix Corporation has decided to read more…
Chinese and Australian businesses looking for overseas opportunities to expand in the healthcare industry should be aware of important regulatory changes that are taking place in both China and Australia. The healthcare industry in both Australia and China is undergoing significant growth that has been accompanied by rapid regulatory change. Both countries have invested significantly read more…
Ahhhh, I love the smell of a freshly printed EUIPO absolute grounds case in the morning! Often the most interesting decisions are those relatively rare beasts in which the initial examination objection is overturned by the Board. In a recent decision, the 4th Board of Appeal had to consider the registrability of HOUSE HUNTERS in read more…
Trouble brewing In the past few years the Australian craft beer market has experienced significant growth, with hundreds of independent breweries springing up around the country. But competition is not always friendly and in 2015 trouble began brewing between two interstate rivals, Stone & Wood and Elixir. The dispute eventually spilled over into the courts, read more…